Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
The growing market for cough, cold, and allergy remedies in Indonesia is closely linked to the phenomenon known as "pancaroba", which refers to the transitional period between the dry and rainy seasons. During this time, characterised by…
Cough, cold and allergy (hay fever) remedies in Romania will see continued growth in current value terms in 2024. This performance is being driven by a higher incidence of viral infections and respiratory issues, prompting Romanians to seek faster…
Total current value sales growth for cough, cold and allergy (hay fever) remedies in North Macedonia in 2024 looks set to be down on 2023. This is partly because pricing pressures are easing as inflation steadily recedes, but also reflects the fact…
Cough, cold and allergy (hay fever) remedies is another consumer health category which remains popular in Cameroon in 2024. Indeed, there is a disturbing rise in coughs and colds in the country, also with seasonal allergies becoming more notable and…
Climate change is directly impacting the cough, cold and allergy (hay fever) category in Tunisia. Compared to previous decades, Tunisia is witnessing notable changes to its climate, with hotter temperatures and shorter winters taking effect. By…
There is expected to be muted constant value growth for cough, cold and allergy (hay fever) remedies in Poland in 2024, with volume growth muted or negative across most product areas. The flu season is not expected to be as bad as in 2023 and this is…
As COVID-19 restrictions have eased in Uzbekistan, the cough, cold and allergy remedy landscape was poised for a recovery. However, the introduction of restrictions and regulations for new and existing players has led to significant challenges. Due…
Cough, cold and allergy (hay fever) remedies is the biggest category in OTC in Ukraine with the most popular products being decongestants, pharyngeal preparations and combination products – cough, cold and allergy (hay fever) remedies. In many…
Manufacturers have raised their prices, leading to double-digit retail value growth on the landscape. Nonetheless, in many cases, consumers have continued to buy expensive branded options, having more confidence in items they are familiar with.…
The market for cough, cold, and allergy remedies in Taiwan is expected to grow in current value terms in 2024, driven by a rise in respiratory infections, compounded by the country’s high asthma prevalence. Environmental pollution is a key factor…
The market for cough, cold, and allergy remedies in Switzerland is anticipated to continue its growth trajectory in 2024, fuelled by erratic weather patterns and a return to normal lifestyles following the pandemic. Cough remedies are expected to be…
Cough, cold and allergy (hay fever) remedies remained the largest product area within consumer health in Sweden in 2024. Consumer demand continues to normalise after the highs of the pandemic, but there are diverging results depending on the…
Value sales of cough, cold and allergy (hay fever) remedies in South Africa continue to rise across the category in 2024, although overall demand is mainly driven by combination products, cough remedies, decongestants, medicated confectionery and…
Responsible conduct during the pandemic, such as wearing face masks, practising social distancing, and frequently washing hands, effectively limited the spread of flu-like viruses and reduced the number of people affected by commonly transmitted…
The weaker value growth seen in cough and cold, allergy (hay fever) remedies in 2024 can be attributed to falling inflation in Serbia and the lower incidence of coughs and colds at the beginning of 2024. Unit prices continued to rise in line with the…
In spite of continuing high inflation, cough, cold and allergy (hay fever remedies) is expected to register healthy constant value growth in Pakistan in 2024. A high incidence of respiratory illnesses is driving growth and this is partly due to…
The widespread availability and affordability of OTC cough, cold and allergy (hay fever) medications in Kenya have made them a popular choice for managing minor respiratory symptoms. Rising pollution levels has been driving sales in 2024, with both…
Cough, cold and allergy (hay fever) remedies are set to post double-digit retail value growth in 2024, benefiting from the change in the exchange rate in Argentina. Argentina’s exchange rate appreciated in the first quarter of 2024, with an immediate…
The market for cough, cold, and allergy remedies in Slovakia is projected to maintain healthy growth in current value terms in 2024. While shortages of certain medicines and inflationary pressures of p[previous years will continue to have a lingering…
Cough, cold and allergy (hay fever) remedies is set to see current value growth in Norway in 2024. Cough, cold and allergy (hay fever) remedies is the largest OTC consumer health category in Norway, and, as such, struggled with rising maturity before…